{"id":"https://genegraph.clinicalgenome.org/r/cea13bfe-b582-43b0-a829-2c2a1b624eabv1.1","type":"EvidenceStrengthAssertion","dc:description":"The H4C5 gene is located on chromosome 6 at 6p22.2 and encodes the H4 clustered histone 5 protein, a core component of nucelosomes. H4C5 was first reported in relation to autosomal dominant Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 3 (TEVANED3) in 2022 (Tessadori et al., PMID: 35202563). TEVANED3 is characterized by intellectual disability/global developmental delay, hypotonia, seizure, microcephaly and short stature. To date, 7 missense variants, including 4 unique and 3 recurrent variants in 18 probands have been reported in two publications and are included in this curation (PMID 35202563; 36987712). Experimental evidence to support this gene-disease relationship association is  from expression and protein interaction data at present. In summary, there is strong evidence to support the relationship between H4C5 and autosomal dominant TEVANED3. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date March 19, 2024 (SOP Version 10.0).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/cea13bfe-b582-43b0-a829-2c2a1b624eab","GCISnapshot":"https://genegraph.clinicalgenome.org/r/934ff2db-b242-49d8-968f-08f8eb7b1310","calculatedEvidenceStrength":"Strong","changes":{"id":"cg:sopChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/934ff2db-b242-49d8-968f-08f8eb7b1310_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-09-26T14:23:08.645Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/934ff2db-b242-49d8-968f-08f8eb7b1310_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-03-19T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/934ff2db-b242-49d8-968f-08f8eb7b1310_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86b6d094-359b-412b-8308-0506135c6f6b","type":"EvidenceLine","dc:description":"Did not score functional data as it is not statistically significant","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86b6d094-359b-412b-8308-0506135c6f6b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/830b25a1-0937-461d-ab38-7cfbe82dd73b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003545.4(H4C5):c.121C>T (p.Arg41Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA363200670"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/86b6d094-359b-412b-8308-0506135c6f6b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 4% of embryos have class II and III developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/886a0c5c-955b-4582-a1fe-7aaea0df8d49","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/886a0c5c-955b-4582-a1fe-7aaea0df8d49_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/dedd5694-1a3b-4e48-b30d-837224666a53","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003545.4(H4C5):c.136C>T (p.Arg46Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA136295386"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/886a0c5c-955b-4582-a1fe-7aaea0df8d49_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 8% of embryos have class II and V developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/57b3504f-4da0-48ed-b474-47c73921bc0a","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/57b3504f-4da0-48ed-b474-47c73921bc0a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/e96eae3f-9d60-4d8a-b177-28704a6dbffc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003545.4(H4C5):c.295T>C (p.Tyr99His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA363201221"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/57b3504f-4da0-48ed-b474-47c73921bc0a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 29% of embryos have class II, III and V developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/749f2bbe-35f9-440d-85eb-4b3708270726","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/749f2bbe-35f9-440d-85eb-4b3708270726_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/dedd5694-1a3b-4e48-b30d-837224666a53"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/749f2bbe-35f9-440d-85eb-4b3708270726_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 8% of embryos have class II and V developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/bbf558be-e3e5-4f74-bd70-6573b07bb4a1","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bbf558be-e3e5-4f74-bd70-6573b07bb4a1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/dedd5694-1a3b-4e48-b30d-837224666a53"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/bbf558be-e3e5-4f74-bd70-6573b07bb4a1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 8% of embryos have class II and V developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d21fff21-8fb6-4f96-9126-22962e5370e3","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d21fff21-8fb6-4f96-9126-22962e5370e3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36987712","allele":{"id":"https://genegraph.clinicalgenome.org/r/e96eae3f-9d60-4d8a-b177-28704a6dbffc"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/d21fff21-8fb6-4f96-9126-22962e5370e3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 29% of embryos have class II, III and V developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9380835a-6708-47c1-a9f3-e9ad7f5f09b7","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9380835a-6708-47c1-a9f3-e9ad7f5f09b7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/6c506ca7-f542-4b03-9feb-057a52fc66ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003545.4(H4C5):c.113T>C (p.Leu38Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA363200650"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/9380835a-6708-47c1-a9f3-e9ad7f5f09b7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 40% of embryos have class II and III developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c9e2e0bf-52b2-4027-9816-d9165b3995b1","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c9e2e0bf-52b2-4027-9816-d9165b3995b1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/a491f530-e464-42e4-b223-de21c353772d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003545.4(H4C5):c.98C>G (p.Pro33Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA363200589"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/c9e2e0bf-52b2-4027-9816-d9165b3995b1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 19% of embryos have class II and V developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/fe20d5b0-798e-4d3e-be62-a15be95c7216","type":"EvidenceLine","dc:description":"Did not score functional data as it is not statistically significant","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe20d5b0-798e-4d3e-be62-a15be95c7216_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/830b25a1-0937-461d-ab38-7cfbe82dd73b"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/fe20d5b0-798e-4d3e-be62-a15be95c7216_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 4% of embryos have class II and III developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c956a039-ec11-47c3-813c-5cffa03ca4fe","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c956a039-ec11-47c3-813c-5cffa03ca4fe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/dedd5694-1a3b-4e48-b30d-837224666a53"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/c956a039-ec11-47c3-813c-5cffa03ca4fe_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 8% of embryos have class II and V developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f7f266f2-aab3-4d1a-ae04-be7b7d238252","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7f266f2-aab3-4d1a-ae04-be7b7d238252_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/dedd5694-1a3b-4e48-b30d-837224666a53"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/f7f266f2-aab3-4d1a-ae04-be7b7d238252_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 8% of embryos have class II and V developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/45deed47-a7e0-438e-b95c-ecfde1032bf3","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/45deed47-a7e0-438e-b95c-ecfde1032bf3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/a2afda82-2587-46e6-a7af-0e38ac712752","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003545.4(H4C5):c.106C>T (p.Arg36Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA363200628"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/45deed47-a7e0-438e-b95c-ecfde1032bf3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 23% of embryos have class II and V developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/85c6bbbe-6aab-40e7-b3df-c7152b8c051e","type":"EvidenceLine","dc:description":"Did not score functional data as it is not statistically significant","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85c6bbbe-6aab-40e7-b3df-c7152b8c051e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/830b25a1-0937-461d-ab38-7cfbe82dd73b"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/85c6bbbe-6aab-40e7-b3df-c7152b8c051e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 4% of embryos have class II and III developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/78ad7460-3bad-4ae1-8bbd-217857ce8bc1","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78ad7460-3bad-4ae1-8bbd-217857ce8bc1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/dedd5694-1a3b-4e48-b30d-837224666a53"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/78ad7460-3bad-4ae1-8bbd-217857ce8bc1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 8% of embryos have class II and V developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a693b608-1b43-458a-901a-9c8a70c94e7c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a693b608-1b43-458a-901a-9c8a70c94e7c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/b5ca19e5-ba99-4036-9de9-0a07bf7ff4c6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003545.4(H4C5):c.95A>C (p.Lys32Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA363200574"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a693b608-1b43-458a-901a-9c8a70c94e7c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 15% of embryos have class II-V developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f64bbba8-eeef-425c-a1ce-0b82302699d4","type":"EvidenceLine","dc:description":"Did not score functional data as it is not statistically significant","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f64bbba8-eeef-425c-a1ce-0b82302699d4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/830b25a1-0937-461d-ab38-7cfbe82dd73b"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/f64bbba8-eeef-425c-a1ce-0b82302699d4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 4% of embryos have class II and III developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e74e720e-275c-4dce-aafe-0d3023023ccc","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e74e720e-275c-4dce-aafe-0d3023023ccc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/e96eae3f-9d60-4d8a-b177-28704a6dbffc"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/e74e720e-275c-4dce-aafe-0d3023023ccc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 29% of embryos have class II, III and V developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/72be05a4-fdbb-42bc-b2b6-b1b8e2eff3a6","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72be05a4-fdbb-42bc-b2b6-b1b8e2eff3a6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35202563","allele":{"id":"https://genegraph.clinicalgenome.org/r/dedd5694-1a3b-4e48-b30d-837224666a53"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/72be05a4-fdbb-42bc-b2b6-b1b8e2eff3a6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional consequences of this variant was evaluated in zebrafish embryos via mRNA microinjection. Early embryonic evaluation were evaluated at 28 hours post fertilization (hpf). About 8% of embryos have class II and V developmental defect (Fig 3D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/934ff2db-b242-49d8-968f-08f8eb7b1310_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/934ff2db-b242-49d8-968f-08f8eb7b1310_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a218655e-ac9c-4d4c-a429-affe83a95718","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b764d27-92c5-4814-b0a0-555b73d66f04","type":"Finding","dc:description":"Human T98G glioblastoma cells were serum-deprived for 72 h to induce quiescence and then stimulated to re-enter the cell cycle with serum\nSynchronously cycling cells were harvested at 4, 21 and 25 h post-stimulation, corresponding to the G1, S and G2 phases of cell cycle, respectively.\nRNA was examined by qRT-PCR: the mRNA levels of histone H4 gene were upregulated in S phase between 5- and 20-fold above the levels in G1 and G2 phases, including H4C5 (H4/J).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16131487","rdfs:label":"H4C5 expression during cell cycle","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/630184ac-26f5-449d-a356-9dbf7176fe51","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e50c23e6-c7c3-4f11-b6ca-ab7810da1557","type":"Finding","dc:description":"Mass spectrometric and immunoblotting analyses for predeposited form of H3.3 complexes identified histone H4 as a common component.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14718166","rdfs:label":"Purification of predeposited histones complexes","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/934ff2db-b242-49d8-968f-08f8eb7b1310_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e1e6455-1d44-4a67-9668-b8e042345310","type":"EvidenceLine","dc:description":"The functional evidence of this H4 protein is from variant in H4C3 gene","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3ad030a-08be-4374-ab74-655bc6942fd1","type":"Finding","dc:description":"Zebrafish embryos expressing the H4K91 mutants showed significant increase in the accumulation of DNA double-strand breaks (DSBs), revealed by increased Î³-H2AX signal (Fig. 2e). Both K91Q- and K91R-expressing embryos displayed anomalous development and abnormal accumulation of cells in S/G2/M phase in the head and caudal regions (Fig. 3a), in agreement with the increases in DSBs and apoptosis observed in these regions. These results demonstrate that expression of histone H4 mutated at K91 during embryonic development results in an increase in DSBs, leading to abnormal cell cycle progression and apoptosis, and suggest that these defects cause the syndromic phenotypes of the patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28920961","rdfs:label":"Functional consequence of germline mutation in histone H4","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1}],"evidenceStrength":"Strong","sequence":9023,"specifiedBy":"GeneValidityCriteria10","strengthScore":13,"subject":{"id":"https://genegraph.clinicalgenome.org/r/gi4PtWJ18Sc","type":"GeneValidityProposition","disease":"obo:MONDO_0030993","gene":"hgnc:4790","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_934ff2db-b242-49d8-968f-08f8eb7b1310-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}